Profiel
Peter Clinton is currently a Director at Amprion, Inc. He previously worked as an Acting Chief Executive Officer at Cricket Wellington, Inc. from 2011 to 2012.
Actieve functies van Peter Clinton
| Bedrijven | Functie | Begin |
|---|---|---|
Amprion, Inc.
 Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Peter Clinton
| Bedrijven | Functie | Einde |
|---|---|---|
| Cricket Wellington, Inc. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Cricket Wellington, Inc. | |
Amprion, Inc.
Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Health Technology |
